TheraRadar
← Back
Data updated: Jul 17, 2026

ARISE

Generics
Pharmaceuticals

ARISE is a generic drug manufacturer with 1 FDA-approved products.

2011
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

ARISE's Key Drugs

ARISE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ARISE's Recent FDA Approvals

New NDA/BLA approvals for ARISE over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ARISE's Therapeutic Areas

Disease areas where ARISE has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ARISE Pipeline Snapshot

Active clinical trials for ARISE across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling